Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Page 1
Optimization of the Enrichment of Circulating Tumor Cells for Downstream Phenotypic Analysis in Patients with Non-Small Cell Lung Cancer Treated with Anti-PD-1 Immunotherapy.
Cancers (Basel). 2020 Jun 12;12(6):1556. doi: 10.3390/cancers12061556.
Cancers (Basel). 2020.
PMID: 32545559
Free PMC article.
IDO and PD-L1 were expressed in 44% and 33% and co-expressed in 19% of CTCs. CTC detection was associated with progressive disease (PD) (p = 0.006), reduced progression-free survival PFS (p = 0.007), and increased risk of relapse (hazard ratio; HR: 10.733; p = 0.026). IDO- …
IDO and PD-L1 were expressed in 44% and 33% and co-expressed in 19% of CTCs. CTC detection was associated with progressive disease (P …
Clinical Relevance of Immune Checkpoints on Circulating Tumor Cells in Breast Cancer.
Papadaki MA, Koutsopoulos AV, Tsoulfas PG, Lagoudaki E, Aggouraki D, Monastirioti A, Koutoulaki C, Apostolopoulou CA, Merodoulaki AC, Papadaki C, Mavroudis D, Agelaki S.
Papadaki MA, et al.
Cancers (Basel). 2020 Feb 6;12(2):376. doi: 10.3390/cancers12020376.
Cancers (Basel). 2020.
PMID: 32041353
Free PMC article.
In metastatic disease, CD47(high)and/orPD-L1(high) CTCs were associated with disease progression (p = 0.005) and shorter progression-free survival (PFS) (p = 0.010), and independently predicted for an increased risk of relapse (HR: 2.719; p = 0.008) and death (HR: 2.398; p …
In metastatic disease, CD47(high)and/orPD-L1(high) CTCs were associated with disease progression (p = 0.005) and shorter progression- …
Item in Clipboard
Cite
Cite